Enhancer RNAs contribute to genome reprogramming driven by a GATA3 noncoding variant in leukaemia

The GATA3 noncoding variant rs3824662 has been implicated in the pathogenesis of Ph-like B-ALL, where it is associated with extensive chromatin reorganisation, resulting in the dysregulation of multiple genes, including CRLF2 overexpression. Given the altered chromatin landscape and increased accessibility of GATA3 binding regions associated with the rs3824662 variant, we investigated the potential role of enhancer RNAs (eRNAs) located near the GATA3 locus in regulating CRLF2 expression. We found that the expression of eRNA_G3, located at chr10:8,443,562-8,449,563, was positively correlated with CRLF2 expression. Notably, eRNA_G3 was significantly upregulated in Ph-like ALL cases carrying the GATA3 rs3824662 variant. These findings suggest that both rs3824662 and eRNAs may cooperatively contribute to the regulatory mechanisms governing GATA3 and CRLF2 expression in Ph-like ALL.

Authors

Institutions

Publication Details

Journal
Scientific Reports
Published
2025-08-09
DOI
https://doi.org/10.1038/s41598-025-10262-0
Primary Topic
RNA modifications and cancer
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Enhancer RNAs contribute to genome reprogramming driven by a GATA3 noncoding variant in leukaemia

Caroline P. Poubel, Ana Luiza Tardem Maciel, Mariana Emerenciano, Caroline Barbieri Blunck et al.
Scientific Reports
RNA modifications and cancer
article

Enhancer RNAs contribute to genome reprogramming driven by a GATA3 noncoding variant in leukaemia

Caroline P. Poubel, Ana Luiza Tardem Maciel, Mariana Emerenciano, Caroline Barbieri Blunck, Rosário Santos, Thayana C. Barbosa, Marcela Braga Mansur, Mariana Boroni
article en

Abstract

The GATA3 noncoding variant rs3824662 has been implicated in the pathogenesis of Ph-like B-ALL, where it is associated with extensive chromatin reorganisation, resulting in the dysregulation of multiple genes, including CRLF2 overexpression. Given the altered chromatin landscape and increased accessibility of GATA3 binding regions associated with the rs3824662 variant, we investigated the potential role of enhancer RNAs (eRNAs) located near the GATA3 locus in regulating CRLF2 expression. We found that the expression of eRNA_G3, located at chr10:8,443,562-8,449,563, was positively correlated with CRLF2 expression. Notably, eRNA_G3 was significantly upregulated in Ph-like ALL cases carrying the GATA3 rs3824662 variant. These findings suggest that both rs3824662 and eRNAs may cooperatively contribute to the regulatory mechanisms governing GATA3 and CRLF2 expression in Ph-like ALL.

Scientific ReportsVol. 15(1)
Blood Cancer UK (GB), Instituto Nacional de Câncer - INCA (BR)
Conselho Nacional de Desenvolvimento Científico e Tecnológico, Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro
Life in Land
Openalex Percentile: Top 82%
RNA modifications and cancer
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.